30-day FRN

mstockstill on DSK4VPTVN1PROD with NOTICES

6874

Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices

chimpanzee and the social group in
which the chimpanzee lives.
Specifically, permissible research, as
described in the ‘‘Standards of Care for
Chimpanzees Held in the Federally
Supported Chimpanzee Sanctuary
System’’ at 42 CFR part 9, includes:
• Visual observation;
• Behavioral studies designed to
improve the establishment and
maintenance of social groups. These
activities may cause stress as a result of
novel interactions between chimpanzees
and caregivers, but they are not
considered invasive as long as they are
intended to maximize the well-being of
the chimpanzees;
• Medical examinations as deemed
necessary to oversee the health of the
chimpanzees, in the least invasive
manner possible. Collection of samples
routinely obtained during a physical
examination for processing during this
time is also considered noninvasive
since a separate event is not required;
• Administration and evaluation of
environmental enrichment used to
promote the psychological well-being of
the chimpanzees; and
• Actions taken to provide essential
medical treatment to an individual
chimpanzee exhibiting symptoms of
illness. This applies only to serious
illness that cannot be treated while the
chimpanzee remains within the colony.
• Observational studies and
collection of biomaterial in the wild
without interfering with the chimpanzee
is also permitted.
These decisions apply to all new or
competing renewals of grant
applications, contract proposals,
intramural protocols, and 3rd party
projects. The NIH may issue future
guidance about the permissible
noninvasive research involving
chimpanzees. Researchers are
encouraged to contact their program
officers for additional information or the
Division of Program Coordination,
Planning, and Strategic Initiatives at
[email protected].
The NIH’s decision to allow the
support of noninvasive research
involving the use of chimpanzees, as
described in this notice, does not affect
requirements for investigators and/or
their institutions to obtain permits from
the U.S. Fish and Wildlife Service, if
applicable, nor does it affect the
responsibility to meet all applicable
veterinary, colony, and husbandry
obligations.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health

National Institutes of Health

National Human Genome Research
Institute; Notice of Closed Meetings

Submission for OMB Review; 30-Day
Comment Request; Application Forms
for the NIDA Summer Research
Internship Program

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, KOMP2 (Knockout Mouse
Phenotyping Program).
Date: March 3, 2016
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NHGRI, 5635FL, NHGRI Twinbrook
Library, Fishers Lane, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Lita Proctor, Ph.D.,
Extramural Research Programs Staff, Program
Director, Human Microbiome Project,
National Human Genome Research Institute,
5635 Fishers Lane, Suite 4076, Bethesda, MD
20892, 301 496–4550, proctorlm@
mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, Sequencing Technology Special
Emphasis Panel.
Date: March 24, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal City Marriott at Reagan
National Airport, 1999 Salon E & D, Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: Ken D. Nakamura, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 5635
Fishers Lane, Suite 4076, MSC 9306,
Rockville, MD 20852, 301–402–0838,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)

Dated: February 2, 2016.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.

Dated: February 4, 2016.
Sylvia Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.

[FR Doc. 2016–02554 Filed 2–8–16; 8:45 am]

[FR Doc. 2016–02538 Filed 2–8–16; 8:45 am]

BILLING CODE 4140–01–P

BILLING CODE 4140–01–P

VerDate Sep<11>2014

17:54 Feb 08, 2016

Jkt 238001

PO 00000

Frm 00047

Fmt 4703

Sfmt 4703

Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on September 2,
2015, Vol. 80, No. 170, on page 53164.
No comments were received. The
purpose of this notice is to allow an
additional 30 days for public comment.
The National Institute of Drug Abuse
(NIDA), National Institutes of Health,
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
Direct Comments to Omb: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed program,
contact: Albert Avila, Ph.D., Director,
Office of Diversity and Health
Disparities, NIDA, NIH, 6001 Executive
Blvd., Room 3106, Rockville, MD 20852,
or call non-toll-free number (301)–443–
0441 or Email your request, including
your address to: [email protected].
Formal requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: NIDA Summer
Research Internship Program 0925Existing Collection in Use Without an
OMB Control Number, National
Institute on Drug Abuse (NIDA),
National Institutes of Health (NIH).
SUMMARY:

E:\FR\FM\09FEN1.SGM

09FEN1

6875

Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices
Need and Use of Information
Collection: The NIDA Summer Research
Internship program introduces high
school and undergraduate students of
underrepresented populations to
substance abuse research through
internships with NIDA grantees at
universities across the United States and
Puerto Rico. Students intern with NIDA
principal investigators for 8–10 weeks
during the summer. The internship
experience may include laboratory
experiments, formal courses, data

collection, data analysis, patient
recruitment, manuscript preparation,
literature reviews and library research.
This outreach and pipeline program
exposes students interested in
biomedical and behavioral research
careers to cutting edge substance abuse
research.
This program fills a significant unmet
need to encourage and support
individuals from underrepresented
groups to pursue careers in substance
abuse research. The NIDA Summer
Research Internship program offers a

unique opportunity to increase the
diversity and creativity of the
biomedical research workforce by
fostering the development of young
talent through the creation of
mentorship and training opportunities
with premier substance abuse research
laboratories around the country.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
350.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Form name

Type of respondent

Application Form ...............................
Application Form ...............................

High School Students .......................
Undergraduates ................................

100
250

MSC 7890, Bethesda, MD 20892, 301–435–
0603, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)

Dated: February 2, 2016.
Genevieve DeAlmeida-Morris,
Project Clearance Liaison, NIDA, NIH.
[FR Doc. 2016–02446 Filed 2–8–16; 8:45 am]
BILLING CODE 4140–01–P

Dated: February 4, 2016.
Sylvia Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2016–02537 Filed 2–8–16; 8:45 am]

National Institutes of Health

BILLING CODE 4140–01–P

National Human Genome Research
Institute; Notice of Closed Meeting

mstockstill on DSK4VPTVN1PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: March 4, 2016.
Time: 11:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Suite
3049, 5635 Fishers Lane, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Barbara J Thomas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2218,

VerDate Sep<11>2014

17:54 Feb 08, 2016

Jkt 238001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; Clinical Trials
Review Committee.
Date: March 3–4, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.

PO 00000

Frm 00048

Fmt 4703

Sfmt 4703

Number of
responses per
respondent

Average
burden per
response
(in hours)

1
1

Total annual
burden hours
1
1

100
250

Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Keary A. Cope, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7190, Bethesda, MD 20892–7924, 301–435–
2222, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: February 3, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–02456 Filed 2–8–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals

E:\FR\FM\09FEN1.SGM

09FEN1